Gordon Chun-Kau ChanDepartment of Medicine & Therapeutics, Prince of Wales Hospital, Carol and Richard Yu PD Research Center, The Chinese University of Hong Kong, Shatin, Hong Kong, China
Agnes Shin-Man ChoyDepartment of Medicine & Therapeutics, Prince of Wales Hospital, Carol and Richard Yu PD Research Center, The Chinese University of Hong Kong, Shatin, Hong Kong, China
Philip Kam-Tao LiDepartment of Medicine & Therapeutics, Prince of Wales Hospital, Carol and Richard Yu PD Research Center, The Chinese University of Hong Kong, Shatin, Hong Kong, China
LiPK, ChowKM, Van de LuijtgaardenMW, JohnsonDW, JagerKJ, MehrotraR, et al: Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol13: 90–103, 2017PubMed
LiPK, ChowKM, Van de LuijtgaardenMW, JohnsonDW, JagerKJ, MehrotraR, et al: Changes in the worldwide epidemiology of peritoneal dialysis. Nat Rev Nephrol 13: 90–103, 2017PubMed)| false
KDOQI; National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis47[Suppl 3]: S11–S145, 2006PubMed
KDOQI; National Kidney Foundation: KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 47[Suppl 3]: S11–S145, 2006PubMed)| false
InkerLA, GramsME, LeveyAS, CoreshJ, CirilloM, CollinsJF, et al; CKD Prognosis Consortium: Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: An individual participant data meta-analysis in a global consortium. Am J Kidney Dis73: 206–217, 2019PubMed
InkerLA, GramsME, LeveyAS, CoreshJ, CirilloM, CollinsJF, et al; CKD Prognosis Consortium: Relationship of estimated GFR and albuminuria to concurrent laboratory abnormalities: An individual participant data meta-analysis in a global consortium. Am J Kidney Dis 73: 206–217, 2019PubMed)| false
PortolésJ, MartínL, BrosetaJJ, CasesA: Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents. Front Med (Lausanne)8: 642296, 2021PubMed
PortolésJ, MartínL, BrosetaJJ, CasesA: Anemia in chronic kidney disease: From pathophysiology and current treatments, to future agents. Front Med (Lausanne) 8: 642296, 2021PubMed)| false
DrüekeTB, ParfreyPS: Summary of the KDIGO guideline on anemia and comment: Reading between the (guide)line(s). Kidney Int 82: 952–960, 2012PubMed)| false
MaJ, DouY, ZhangH, ThijssenS, WilliamsS, KuntsevichV, et al: Correlation between inflammatory biomarkers and red blood cell life span in chronic hemodialysis patients. Blood Purif43: 200–205, 2017PubMed
MaJ, DouY, ZhangH, ThijssenS, WilliamsS, KuntsevichV, et al: Correlation between inflammatory biomarkers and red blood cell life span in chronic hemodialysis patients. Blood Purif 43: 200–205, 2017PubMed)| false
ShepshelovichD, Rozen-ZviB, AvniT, GafterU, Gafter-GviliA: Intravenous versus oral iron supplementation for the treatment of anemia in CKD: An updated systematic review and meta-analysis. Am J Kidney Dis68: 677–690, 2016PubMed
ShepshelovichD, Rozen-ZviB, AvniT, GafterU, Gafter-GviliA: Intravenous versus oral iron supplementation for the treatment of anemia in CKD: An updated systematic review and meta-analysis. Am J Kidney Dis 68: 677–690, 2016PubMed)| false
WongMMY, TuC, LiY, PerlmanRL, Pecoits-FilhoR, LopesAA, et al; CKDopps Investigators: Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: Often unmeasured, variably treated. Clin Kidney J13: 613–624, 2019PubMed
WongMMY, TuC, LiY, PerlmanRL, Pecoits-FilhoR, LopesAA, et al; CKDopps Investigators: Anemia and iron deficiency among chronic kidney disease Stages 3-5ND patients in the Chronic Kidney Disease Outcomes and Practice Patterns Study: Often unmeasured, variably treated. Clin Kidney J 13: 613–624, 2019PubMed)| false
LopesMB, TuC, ZeeJ, GuedesM, PisoniRL, RobinsonBM, et al: A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: A multinational analysis of CKDopps. Sci Rep11: 1784, 2021PubMed
LopesMB, TuC, ZeeJ, GuedesM, PisoniRL, RobinsonBM, et al: A real-world longitudinal study of anemia management in non-dialysis-dependent chronic kidney disease patients: A multinational analysis of CKDopps. Sci Rep 11: 1784, 2021PubMed)| false
LocatelliF, CovicA, EckardtKU, WiecekA, VanholderR; ERA-EDTA ERBP Advisory Board: Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant24: 348–354, 2009PubMed
LocatelliF, CovicA, EckardtKU, WiecekA, VanholderR; ERA-EDTA ERBP Advisory Board: Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 24: 348–354, 2009PubMed)| false
National Institute for Health and Care Excellence: Chronic Kidney Disease: Managing Anaemia. NICE Guidelines (NG203), 2021. Available at: https://www.nice.org.uk/guidance/ng203. Accessed September 2022.
National Institute for Health and Care Excellence: Chronic Kidney Disease: Managing Anaemia. NICE Guidelines (NG203), 2021. Available at: https://www.nice.org.uk/guidance/ng203. Accessed September 2022.)| false
LocatelliF, HannedoucheT, FishbaneS, MorganZ, OgueyD, WhiteWB: Cardiovascular safety and all-cause mortality of methoxy polyethylene glycol-epoetin beta and other erythropoiesis-stimulating agents in anemia of CKD: A randomized noninferiority trial. Clin J Am Soc Nephrol14: 1701–1710, 2019PubMed
LocatelliF, HannedoucheT, FishbaneS, MorganZ, OgueyD, WhiteWB: Cardiovascular safety and all-cause mortality of methoxy polyethylene glycol-epoetin beta and other erythropoiesis-stimulating agents in anemia of CKD: A randomized noninferiority trial. Clin J Am Soc Nephrol 14: 1701–1710, 2019PubMed)| false
WetmoreJB, PengY, MondaKL, KatsAM, KimDH, BradburyBD, et al: Trends in anemia management practices in patients receiving hemodialysis and peritoneal dialysis: A retrospective cohort analysis. Am J Nephrol41: 354–361, 2015PubMed
LiPKT, ChoyASM, BavanandanS, ChenW, FooM, KanjanabuchT, et al: Anemia management in peritoneal dialysis: Perspectives from the Asia Pacific region. Kidney Med3: 405–411, 2021PubMed
LiPKT, ChoyASM, BavanandanS, ChenW, FooM, KanjanabuchT, et al: Anemia management in peritoneal dialysis: Perspectives from the Asia Pacific region. Kidney Med 3: 405–411, 2021PubMed)| false
MannsBJ, WhiteCT, MadoreF, MoistLM, KlarenbachSW, BarrettBJ, et al: Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease. Kidney Int Suppl74: S1–S3, 2008PubMed
MannsBJ, WhiteCT, MadoreF, MoistLM, KlarenbachSW, BarrettBJ, et al: Introduction to the Canadian Society of Nephrology clinical practice guidelines for the management of anemia associated with chronic kidney disease. Kidney Int Suppl 74: S1–S3, 2008PubMed)| false
LocatelliF, BárányP, CovicA, De FranciscoA, Del VecchioL, GoldsmithD, et al; ERA-EDTA ERBP Advisory Board: Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European renal best practice position statement. Nephrol Dial Transplant28: 1346–1359, 2013PubMed
LocatelliF, BárányP, CovicA, De FranciscoA, Del VecchioL, GoldsmithD, et al; ERA-EDTA ERBP Advisory Board: Kidney disease: Improving global outcomes guidelines on anaemia management in chronic kidney disease: A European renal best practice position statement. Nephrol Dial Transplant 28: 1346–1359, 2013PubMed)| false
GabrielDP, CaramoriJT, MartimLC, BarrettiP, BalbiAL: High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl73: S87–S93, 2008PubMed
GabrielDP, CaramoriJT, MartimLC, BarrettiP, BalbiAL: High volume peritoneal dialysis vs daily hemodialysis: A randomized, controlled trial in patients with acute kidney injury. Kidney Int Suppl 73: S87–S93, 2008PubMed)| false
PonceD, BerbelMN, AbrãoJM, GoesCR, BalbiAL: A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients. Int Urol Nephrol45: 869–878, 2013PubMed
PonceD, BerbelMN, AbrãoJM, GoesCR, BalbiAL: A randomized clinical trial of high volume peritoneal dialysis versus extended daily hemodialysis for acute kidney injury patients. Int Urol Nephrol 45: 869–878, 2013PubMed)| false
ShanmugalingamR, MakrisA, HassanHC, LiY, DeGuzmanI, NandakobanH, et al: The utility of sonographic assessment in selecting patients for percutaneous insertion of peritoneal dialysis catheter. Perit Dial Int37: 434–442, 2017PubMed
ShanmugalingamR, MakrisA, HassanHC, LiY, DeGuzmanI, NandakobanH, et al: The utility of sonographic assessment in selecting patients for percutaneous insertion of peritoneal dialysis catheter. Perit Dial Int 37: 434–442, 2017PubMed)| false
PonceD, BerbelMN, Regina de GoesC, AlmeidaCT, BalbiAL: High-volume peritoneal dialysis in acute kidney injury: Indications and limitations. Clin J Am Soc Nephrol7: 887–894, 2012PubMed
PonceD, BritoGA, AbrãoJG, BalbAL: Different prescribed doses of high-volume peritoneal dialysis and outcome of patients with acute kidney injury. Adv Perit Dial27: 118–124, 2011PubMed
ParapiboonW, JamratpanT: Intensive versus minimal standard dosage for peritoneal dialysis in acute kidney injury: A randomized pilot study. Perit Dial Int37: 523–528, 2017PubMed
ParapiboonW, JamratpanT: Intensive versus minimal standard dosage for peritoneal dialysis in acute kidney injury: A randomized pilot study. Perit Dial Int 37: 523–528, 2017PubMed)| false
ChenW, CaplinN, El ShamyO, SharmaS, SourialMY, RossMJ, et al; NYC-PD Consortium: Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: A multicenter observational study. Kidney Int100: 2–5, 2021PubMed
ChenW, CaplinN, El ShamyO, SharmaS, SourialMY, RossMJ, et al; NYC-PD Consortium: Use of peritoneal dialysis for acute kidney injury during the COVID-19 pandemic in New York City: A multicenter observational study. Kidney Int 100: 2–5, 2021PubMed)| false
El ShamyO, PatelN, AbdelbasetMH, ChenetL, TokitaJ, LooksteinR, et al: Acute start peritoneal dialysis during the COVID-19 pandemic: Outcomes and experiences. J Am Soc Nephrol31: 1680–1682, 2020PubMed
El ShamyO, PatelN, AbdelbasetMH, ChenetL, TokitaJ, LooksteinR, et al: Acute start peritoneal dialysis during the COVID-19 pandemic: Outcomes and experiences. J Am Soc Nephrol 31: 1680–1682, 2020PubMed)| false
SourialMY, GoneA, UribarriJ, SrivatanaV, SharmaS, ShimonovD, et al; New York City Peritoneal Dialysis Consortium: Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study. Perit Dial Int43: 13–22, 2023PubMed
SourialMY, GoneA, UribarriJ, SrivatanaV, SharmaS, ShimonovD, et al; New York City Peritoneal Dialysis Consortium: Outcomes of PD for AKI treatment during COVID-19 in New York City: A multicenter study. Perit Dial Int 43: 13–22, 2023PubMed)| false
BowesE, JoslinJ, Braide-AzikiweDCB, TulleyC, BramhamK, SahaS, et al: Acute peritoneal dialysis with percutaneous catheter insertion for COVID-19-associated acute kidney injury in intensive care: Experience from a UK tertiary center. Kidney Int Rep6: 265–271, 2021PubMed
BowesE, JoslinJ, Braide-AzikiweDCB, TulleyC, BramhamK, SahaS, et al: Acute peritoneal dialysis with percutaneous catheter insertion for COVID-19-associated acute kidney injury in intensive care: Experience from a UK tertiary center. Kidney Int Rep 6: 265–271, 2021PubMed)| false
CaplinNJ, ZhdanovaO, TandonM, ThompsonN, PatelD, SoomroQ, et al: Acute peritoneal dialysis during the COVID-19 pandemic at Bellevue Hospital in New York City. Kidney3601: 1345–1352, 2020PubMed
CaplinNJ, ZhdanovaO, TandonM, ThompsonN, PatelD, SoomroQ, et al: Acute peritoneal dialysis during the COVID-19 pandemic at Bellevue Hospital in New York City. Kidney360 1: 1345–1352, 2020PubMed)| false
SoomroQH, MukherjeeV, AmerlingR, CaplinN: Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: Prone to complications?Perit Dial Int41: 328–332, 2021PubMed
SoomroQH, MukherjeeV, AmerlingR, CaplinN: Case series of acute peritoneal dialysis in the prone position for acute kidney injury during the Covid-19 pandemic: Prone to complications?Perit Dial Int 41: 328–332, 2021PubMed)| false
FouqueD, Kalantar-ZadehK, KoppleJ, CanoN, ChauveauP, CuppariL, et al: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int73: 391–398, 2008PubMed
FouqueD, Kalantar-ZadehK, KoppleJ, CanoN, ChauveauP, CuppariL, et al: A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 73: 391–398, 2008PubMed)| false
CarreroJJ, ThomasF, NagyK, ArogundadeF, AvesaniCM, ChanM, et al: Global prevalence of protein-energy wasting in kidney disease: A meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr28: 380–392, 2018PubMed
CarreroJJ, ThomasF, NagyK, ArogundadeF, AvesaniCM, ChanM, et al: Global prevalence of protein-energy wasting in kidney disease: A meta-analysis of contemporary observational studies from the International Society of Renal Nutrition and Metabolism. J Ren Nutr 28: 380–392, 2018PubMed)| false
RenM, ShengQ, XieX, ZhangX, HanF, ChenJ: Geriatric nutritional risk index is associated with mortality in peritoneal dialysis patients. Intern Med J50: 470–476, 2020PubMed
RenM, ShengQ, XieX, ZhangX, HanF, ChenJ: Geriatric nutritional risk index is associated with mortality in peritoneal dialysis patients. Intern Med J 50: 470–476, 2020PubMed)| false
CarreroJJ, StenvinkelP, CuppariL, IkizlerTA, Kalantar-ZadehK, KaysenG, et al: Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr23: 77–90, 2013PubMed
CarreroJJ, StenvinkelP, CuppariL, IkizlerTA, Kalantar-ZadehK, KaysenG, et al: Etiology of the protein-energy wasting syndrome in chronic kidney disease: A consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr 23: 77–90, 2013PubMed)| false
IkizlerTA, BurrowesJD, Byham-GrayLD, CampbellKL, CarreroJJ, ChanW, et al: KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 update. Am J Kidney Dis76[Suppl 1]: S1–S107, 2020PubMed
WangAY, BrimbleKS, BrunierG, HoltSG, JhaV, JohnsonDW, et al: ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I—Assessment and management of various cardiovascular risk factors. Perit Dial Int35: 379–387, 2015PubMed
WangAY, BrimbleKS, BrunierG, HoltSG, JhaV, JohnsonDW, et al: ISPD cardiovascular and metabolic guidelines in adult peritoneal dialysis patients part I—Assessment and management of various cardiovascular risk factors. Perit Dial Int 35: 379–387, 2015PubMed)| false
SnyderJJ, FoleyRN, GilbertsonDT, VoneshEF, CollinsAJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int64: 1838–1844, 2003PubMed
SnyderJJ, FoleyRN, GilbertsonDT, VoneshEF, CollinsAJ: Body size and outcomes on peritoneal dialysis in the United States. Kidney Int 64: 1838–1844, 2003PubMed)| false
StackAG, MurthyBV, MolonyDA: Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States. Kidney Int65: 2398–2408, 2004PubMed
StackAG, MurthyBV, MolonyDA: Survival differences between peritoneal dialysis and hemodialysis among “large” ESRD patients in the United States. Kidney Int 65: 2398–2408, 2004PubMed)| false
VergerC, RoncoC, Van BiesenW, HeafJ, VrtovsnikF, Vera RiveraM, et al: Association of prescription with body composition and patient outcomes in incident peritoneal dialysis patients. Front Med (Lausanne)8: 737165, 2021PubMed
VergerC, RoncoC, Van BiesenW, HeafJ, VrtovsnikF, Vera RiveraM, et al: Association of prescription with body composition and patient outcomes in incident peritoneal dialysis patients. Front Med (Lausanne) 8: 737165, 2021PubMed)| false
ChoyAS-M, ChowK-M, KwanBC-H, ChengPM-S, KwongVW-K, PangW-F, et al: Weight change during the first year of peritoneal dialysis: Risk factors and prognostic implications. Hong Kong J Nephrol17: 28–35, 2015
ChoyAS-M, ChowK-M, KwanBC-H, ChengPM-S, KwongVW-K, PangW-F, et al: Weight change during the first year of peritoneal dialysis: Risk factors and prognostic implications. Hong Kong J Nephrol 17: 28–35, 2015)| false
ThanWH, NgJKC, ChanGCK, FungW, SzetoCC: The prognostic impact of weight gain after peritoneal dialysis. Nephrol Dial Transplant ;36[Suppl 1],gfab101.0026, 2021
ParthasarathyR, OeiE, FanSL: Clinical value of body composition monitor to evaluate lean and fat tissue mass in peritoneal dialysis. Eur J Clin Nutr73: 1520–1528, 2019PubMed
ParthasarathyR, OeiE, FanSL: Clinical value of body composition monitor to evaluate lean and fat tissue mass in peritoneal dialysis. Eur J Clin Nutr 73: 1520–1528, 2019PubMed)| false
NgJK, ChanGC, KamKK, TianN, ThanWH, ChengPM, et al: The impact of volume overload on the longitudinal change of adipose and lean tissue mass in incident chinese peritoneal dialysis patients. Nutrients14: 4076, 2022PubMed
NgJK, ChanGC, KamKK, TianN, ThanWH, ChengPM, et al: The impact of volume overload on the longitudinal change of adipose and lean tissue mass in incident chinese peritoneal dialysis patients. Nutrients 14: 4076, 2022PubMed)| false
KimC, KimJK, LeeHS, KimSG, SongYR: Longitudinal changes in body composition are associated with all-cause mortality in patients on peritoneal dialysis. Clin Nutr40: 120–126, 2021PubMed
KimC, KimJK, LeeHS, KimSG, SongYR: Longitudinal changes in body composition are associated with all-cause mortality in patients on peritoneal dialysis. Clin Nutr 40: 120–126, 2021PubMed)| false
PopovicV, ZerahnB, HeafJG: Comparison of dual energy x-ray absorptiometry and bioimpedance in assessing body composition and nutrition in peritoneal dialysis patients. J Ren Nutr27: 355–363, 2017PubMed
PopovicV, ZerahnB, HeafJG: Comparison of dual energy x-ray absorptiometry and bioimpedance in assessing body composition and nutrition in peritoneal dialysis patients. J Ren Nutr 27: 355–363, 2017PubMed)| false
ChamneyPW, WabelP, MoisslUM, MüllerMJ, Bosy-WestphalA, KorthO, et al: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr85: 80–89, 2007PubMed
ChamneyPW, WabelP, MoisslUM, MüllerMJ, Bosy-WestphalA, KorthO, et al: A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 85: 80–89, 2007PubMed)| false
YoowannakulS, TangvoraphonkchaiK, DavenportA: The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance. Eur J Clin Nutr72: 381–387, 2018PubMed
YoowannakulS, TangvoraphonkchaiK, DavenportA: The prevalence of muscle wasting (sarcopenia) in peritoneal dialysis patients varies with ethnicity due to differences in muscle mass measured by bioimpedance. Eur J Clin Nutr 72: 381–387, 2018PubMed)| false
SzetoCC, KongJ, WuAK, WongTY, WangAY, LiPK: The role of lean body mass as a nutritional index in Chinese peritoneal dialysis patients--comparison of creatinine kinetics method and anthropometric method. Perit Dial Int20: 708–714, 2000PubMed
SzetoCC, KongJ, WuAK, WongTY, WangAY, LiPK: The role of lean body mass as a nutritional index in Chinese peritoneal dialysis patients--comparison of creatinine kinetics method and anthropometric method. Perit Dial Int 20: 708–714, 2000PubMed)| false
Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol7: 198–207, 1996PubMed
Canada-USA (CANUSA) Peritoneal Dialysis Study Group: Adequacy of dialysis and nutrition in continuous peritoneal dialysis: Association with clinical outcomes. J Am Soc Nephrol 7: 198–207, 1996PubMed)| false
ChanGC, NgJK, ChowKM, KwongVW, PangWF, ChengPM, et al: Impact of frailty and its inter-relationship with lean tissue wasting and malnutrition on kidney transplant waitlist candidacy and delisting. Clin Nutr40: 5620–5629, 2021PubMed
ChanGC, NgJK, ChowKM, KwongVW, PangWF, ChengPM, et al: Impact of frailty and its inter-relationship with lean tissue wasting and malnutrition on kidney transplant waitlist candidacy and delisting. Clin Nutr 40: 5620–5629, 2021PubMed)| false
ChanGC, NgJK, ChowKM, KwanBC, KwongVW, PangWF, et al: Depression does not predict clinical outcome of Chinese peritoneal Dialysis patients after adjusting for the degree of frailty. BMC Nephrol21: 329, 2020PubMed
ChanGC, NgJK, ChowKM, KwanBC, KwongVW, PangWF, et al: Depression does not predict clinical outcome of Chinese peritoneal Dialysis patients after adjusting for the degree of frailty. BMC Nephrol 21: 329, 2020PubMed)| false
ChanGC, N GJK, ChowKM, KwongVW, PangWF, ChengPM, et al: Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients. PLoS One15: e0241242, 2020PubMed
ChanGC, N GJK, ChowKM, KwongVW, PangWF, ChengPM, et al: Interaction between central obesity and frailty on the clinical outcome of peritoneal dialysis patients. PLoS One 15: e0241242, 2020PubMed)| false
ChanGC, NgJK, ChowKM, ChengPM, LawMC, LeungCB, et al: Polypharmacy predicts onset and transition of frailty, malnutrition, and adverse outcomes in peritoneal dialysis patient. J Nutr Health Aging26: 1054–1060, 2022PubMed
PaudelK, VisserA, BurkeS, SamadN, FanSL: Can bioimpedance measurements of lean and fat tissue mass replace subjective global assessments in peritoneal dialysis patients?J Ren Nutr25: 480–487, 2015PubMed
PaudelK, VisserA, BurkeS, SamadN, FanSL: Can bioimpedance measurements of lean and fat tissue mass replace subjective global assessments in peritoneal dialysis patients?J Ren Nutr 25: 480–487, 2015PubMed)| false
Kalantar-ZadehK, KoppleJD, BlockG, HumphreysMH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis38: 1251–1263, 2001PubMed
Kalantar-ZadehK, KoppleJD, BlockG, HumphreysMH: A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis 38: 1251–1263, 2001PubMed)| false
ChanJY, CheKI, LamKM, ChowKM, ChungKY, LiPK, et al: Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients. Nephrology (Carlton)12: 130–134, 2007PubMed
ChanJY, CheKI, LamKM, ChowKM, ChungKY, LiPK, et al: Comprehensive malnutrition inflammation score as a marker of nutritional status in Chinese peritoneal dialysis patients. Nephrology (Carlton) 12: 130–134, 2007PubMed)| false
Cueto-ManzanoAM, Romero-GarcíaARJ, Cortés-SanabriaL, Márquez-HerreraRM, Martin-Del-CampoF, Jacobo-AriasF, et al: Systemic inflammation may limit the effect of protein supplement on nutritional status in peritoneal dialysis. Clin Nutr ESPEN49: 307–313, 2022PubMed
Cueto-ManzanoAM, Romero-GarcíaARJ, Cortés-SanabriaL, Márquez-HerreraRM, Martin-Del-CampoF, Jacobo-AriasF, et al: Systemic inflammation may limit the effect of protein supplement on nutritional status in peritoneal dialysis. Clin Nutr ESPEN 49: 307–313, 2022PubMed)| false
ChungSH, HeimbürgerO, StenvinkelP, BergströmJ, LindholmB: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant16: 2240–2245, 2001PubMed
ChungSH, HeimbürgerO, StenvinkelP, BergströmJ, LindholmB: Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis. Nephrol Dial Transplant 16: 2240–2245, 2001PubMed)| false
ThanWH, ChanGC-K, NgJK-C, SzetoC-C: The role of obesity on chronic kidney disease development, progression, and cardiovascular complications. Adv Biomarker Sci Technol.2: 24–34, 2020
ThanWH, ChanGC-K, NgJK-C, SzetoC-C: The role of obesity on chronic kidney disease development, progression, and cardiovascular complications. Adv Biomarker Sci Technol. 2: 24–34, 2020)| false
SzetoCC, KwanBC, ChowKM, LaiKB, ChungKY, LeungCB, et al: Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol3: 431–436, 2008PubMed
SzetoCC, KwanBC, ChowKM, LaiKB, ChungKY, LeungCB, et al: Endotoxemia is related to systemic inflammation and atherosclerosis in peritoneal dialysis patients. Clin J Am Soc Nephrol 3: 431–436, 2008PubMed)| false
McIntyreCW, HarrisonLE, EldehniMT, JefferiesHJ, SzetoCC, JohnSG, et al: Circulating endotoxemia: A novel factor in systemic inflammation and cardiovascular disease in chronic kidney disease. Clin J Am Soc Nephrol6: 133–141, 2011PubMed
SzetoCC, KwanBC, ChowKM, KwokJS, LaiKB, ChengPM, et al: Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. PLoS One10: e0125162, 2015PubMed
SzetoCC, KwanBC, ChowKM, KwokJS, LaiKB, ChengPM, et al: Circulating bacterial-derived DNA fragment level is a strong predictor of cardiovascular disease in peritoneal dialysis patients. PLoS One 10: e0125162, 2015PubMed)| false
PoonPY, NgJK, FungWW, ChowKM, KwanBC, LiPK, et al: Relationship between plasma endocan level and clinical outcome of chinese peritoneal dialysis patients. Kidney Blood Press Res 44: 1259–1270, 2019PubMed)| false
KwanBC, ChowKM, LeungCB, LawMC, ChengPM, YuV, et al: Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis. Nephrol Dial Transplant28: 2139–2145, 2013PubMed
KwanBC, ChowKM, LeungCB, LawMC, ChengPM, YuV, et al: Circulating bacterial-derived DNA fragments as a marker of systemic inflammation in peritoneal dialysis. Nephrol Dial Transplant 28: 2139–2145, 2013PubMed)| false
TianN, LiL, NgJK, LiPK: The potential benefits and controversies of probiotics use in patients at different stages of chronic kidney disease. Nutrients14: 4044, 2022PubMed
TianN, LiL, NgJK, LiPK: The potential benefits and controversies of probiotics use in patients at different stages of chronic kidney disease. Nutrients 14: 4044, 2022PubMed)| false
SzetoCC, WongTY, LeungCB, WangAY, LawMC, LuiSF, et al: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int58: 400–407, 2000PubMed
SzetoCC, WongTY, LeungCB, WangAY, LawMC, LuiSF, et al: Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 58: 400–407, 2000PubMed)| false
SzetoCC, WongTY, ChowKM, LeungCB, WangAY, LuiSF, et al: The impact of increasing the daytime dialysis exchange frequency on peritoneal dialysis adequacy and nutritional status of Chinese anuric patients. Perit Dial Int22: 197–203, 2002PubMed
SzetoCC, WongTY, ChowKM, LeungCB, WangAY, LuiSF, et al: The impact of increasing the daytime dialysis exchange frequency on peritoneal dialysis adequacy and nutritional status of Chinese anuric patients. Perit Dial Int 22: 197–203, 2002PubMed)| false
SteinA, MoorhouseJ, Iles-SmithH, BakerF, JohnstoneJ, JamesG, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int52: 1089–1095, 1997PubMed
SteinA, MoorhouseJ, Iles-SmithH, BakerF, JohnstoneJ, JamesG, et al: Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int 52: 1089–1095, 1997PubMed)| false
SzetoCC, WongTY, ChowKM, LeungCB, LiPK: Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: A randomized placebo-control trial. J Am Soc Nephrol14: 2119–2126, 2003PubMed
SzetoCC, WongTY, ChowKM, LeungCB, LiPK: Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: A randomized placebo-control trial. J Am Soc Nephrol 14: 2119–2126, 2003PubMed)| false
SzetoCC, ChanGC, NgJK, ChowKM, KwanBC, ChengPM, et al: Depression and physical frailty have additive effect on the nutritional status and clinical outcome of chinese peritoneal dialysis. Kidney Blood Press Res43: 914–923, 2018PubMed
SzetoCC, ChanGC, NgJK, ChowKM, KwanBC, ChengPM, et al: Depression and physical frailty have additive effect on the nutritional status and clinical outcome of chinese peritoneal dialysis. Kidney Blood Press Res 43: 914–923, 2018PubMed)| false
MahJY, ChoySW, RobertsMA, DesaiAM, CorkenM, GwiniSM, et al: Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev5: CD012616, 2020PubMed
MahJY, ChoySW, RobertsMA, DesaiAM, CorkenM, GwiniSM, et al: Oral protein-based supplements versus placebo or no treatment for people with chronic kidney disease requiring dialysis. Cochrane Database Syst Rev 5: CD012616, 2020PubMed)| false
TjiongHL, van den BergJW, WattimenaJL, RietveldT, van DijkLJ, van der WielAM, et al: Dialysate as food: Combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol16: 1486–1493, 2005PubMed
TjiongHL, van den BergJW, WattimenaJL, RietveldT, van DijkLJ, van der WielAM, et al: Dialysate as food: Combined amino acid and glucose dialysate improves protein anabolism in renal failure patients on automated peritoneal dialysis. J Am Soc Nephrol 16: 1486–1493, 2005PubMed)| false
LiFK, ChanLY, WooJC, HoSK, LoWK, LaiKN, et al: A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis42: 173–183, 2003PubMed
LiFK, ChanLY, WooJC, HoSK, LoWK, LaiKN, et al: A 3-year, prospective, randomized, controlled study on amino acid dialysate in patients on CAPD. Am J Kidney Dis 42: 173–183, 2003PubMed)| false
LiPK, ChanGC, ChenJ, ChenHC, ChengYL, FanSL, et al: Tackling dialysis burden around the world: A global challenge. Kidney Dis 7: 167–175, 2021PubMed)| false
LiPK, LuW, MakSK, BoudvilleN, YuX, WuMJ, et al: Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology (Carlton)27: 787–794, 2022PubMed
LiPK, LuW, MakSK, BoudvilleN, YuX, WuMJ, et al: Peritoneal dialysis first policy in Hong Kong for 35 years: Global impact. Nephrology (Carlton) 27: 787–794, 2022PubMed)| false
SzetoCC, LoWK, LiPK: Clinical practice guidelines for the provision of renal service in Hong Kong: Peritoneal dialysis. Nephrology (Carlton)24[Suppl 1]: 27–40, 2019PubMed
SzetoCC, LoWK, LiPK: Clinical practice guidelines for the provision of renal service in Hong Kong: Peritoneal dialysis. Nephrology (Carlton) 24[Suppl 1]: 27–40, 2019PubMed)| false
HtayH, ChoY, PascoeEM, DarssanD, Nadeau-FredetteAC, HawleyC, et al: Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis. Clin J Am Soc Nephrol12: 1090–1099, 2017PubMed
HtayH, ChoY, PascoeEM, DarssanD, Nadeau-FredetteAC, HawleyC, et al: Multicenter registry analysis of center characteristics associated with technique failure in patients on incident peritoneal dialysis. Clin J Am Soc Nephrol 12: 1090–1099, 2017PubMed)| false
ManeraKE, JohnsonDW, CraigJC, ShenJI, GutmanT, ChoY, et al; SONG-PD Workshop Investigators: Establishing a core outcome set for peritoneal dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) consensus workshop. Am J Kidney Dis75: 404–412, 2020PubMed
ManeraKE, JohnsonDW, CraigJC, ShenJI, GutmanT, ChoY, et al; SONG-PD Workshop Investigators: Establishing a core outcome set for peritoneal dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) consensus workshop. Am J Kidney Dis 75: 404–412, 2020PubMed)| false
LiPK, SzetoCC, PirainoB, de ArteagaJ, FanS, FigueiredoAE, et al: ISPD peritonitis recommendations: 2016 update on prevention and treatment. Perit Dial Int 36: 481–508, 2016PubMed)| false
PerlJ, FullerDS, BieberBA, BoudvilleN, KanjanabuchT, ItoY, et al: Peritoneal dialysis-related infection rates and outcomes: Results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis76: 42–53, 2020PubMed
PerlJ, FullerDS, BieberBA, BoudvilleN, KanjanabuchT, ItoY, et al: Peritoneal dialysis-related infection rates and outcomes: Results from the peritoneal dialysis outcomes and practice patterns study (PDOPPS). Am J Kidney Dis 76: 42–53, 2020PubMed)| false
MarshallMR: A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit Dial Int42: 39–47, 2022PubMed
MarshallMR: A systematic review of peritoneal dialysis-related peritonitis rates over time from national or regional population-based registries and databases. Perit Dial Int 42: 39–47, 2022PubMed)| false
GweonTG, JungSH, KimSW, LeeKM, CheungDY, LeeBI, et al: Risk factors for peritonitis in patients on continuous ambulatory peritoneal dialysis who undergo colonoscopy: A retrospective multicentre study. BMC Gastroenterol19: 175, 2019PubMed
SuzukiY, MizunoM, KojimaH, SatoY, KimH, KinashiH, et al: Oral antibiotics are effective for preventing colonoscopy-associated peritonitis as a preemptive therapy in patients on peritoneal dialysis. Intern Med60: 353–356, 2021PubMed
SuzukiY, MizunoM, KojimaH, SatoY, KimH, KinashiH, et al: Oral antibiotics are effective for preventing colonoscopy-associated peritonitis as a preemptive therapy in patients on peritoneal dialysis. Intern Med 60: 353–356, 2021PubMed)| false
SzetoCC, ChowKM, KwanBC, LeungCB, ChungKY, LawMC, et al: Hypokalemia in Chinese peritoneal dialysis patients: Prevalence and prognostic implication. Am J Kidney Dis46: 128–135, 2005PubMed
DaviesSJ, ZhaoJ, MorgensternH, ZeeJ, BieberB, FullerDS, et al; PDOPPS Dialysis Prescription and Fluid Management Working Group: Low serum potassium levels and clinical outcomes in peritoneal dialysis-international results from PDOPPS. Kidney Int Rep6: 313–324, 2020PubMed
MuH, YangM, ZhangY, ZhangY, WangJ, YuanW, et al: Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: A case report and review of the literatures. BMC Nephrol21: 102, 2020PubMed
MuH, YangM, ZhangY, ZhangY, WangJ, YuanW, et al: Pet-related Pasteurella multocida induced peritonitis in peritoneal dialysis: A case report and review of the literatures. BMC Nephrol 21: 102, 2020PubMed)| false
BoudvilleN, McCulloughK, BieberB, PisoniR, KanjanabuchT, KawanishiH, et al: A different PET test: The relationship between pet ownership and peritonitis risk in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit Dial Int43: 263–267, 2023PubMed
BoudvilleN, McCulloughK, BieberB, PisoniR, KanjanabuchT, KawanishiH, et al: A different PET test: The relationship between pet ownership and peritonitis risk in the Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS). Perit Dial Int 43: 263–267, 2023PubMed)| false
MuthucumaranaK, HowsonP, CrawfordD, BurrowsS, SwaminathanR, IrishA: The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis Patients: The PROMPT study. Kidney Int Rep1: 65–72, 2016PubMed
MuthucumaranaK, HowsonP, CrawfordD, BurrowsS, SwaminathanR, IrishA: The relationship between presentation and the time of initial administration of antibiotics with outcomes of peritonitis in peritoneal dialysis Patients: The PROMPT study. Kidney Int Rep 1: 65–72, 2016PubMed)| false
OkiR, TsujiS, HamasakiY, KomaruY, MiyamotoY, MatsuuraR, et al: Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis. Sci Rep11: 6547, 2021PubMed
OkiR, TsujiS, HamasakiY, KomaruY, MiyamotoY, MatsuuraR, et al: Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis. Sci Rep 11: 6547, 2021PubMed)| false
LiPK, IpM, LawMC, SzetoCC, LeungCB, WongTY, et al: Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis. Perit Dial Int20: 232–234, 2000PubMed
LiPK, IpM, LawMC, SzetoCC, LeungCB, WongTY, et al: Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis. Perit Dial Int 20: 232–234, 2000PubMed)| false
KitrungphaiboonT, PuapatanakulP, ChuengsamanP, TiskajornsiriK, HalueG, SiribamrungwongM, et al: Intraperitoneal cefepime monotherapy versus combination therapy of cefazolin plus ceftazidime for empirical treatment of CAPD-associated peritonitis: A multicenter, open-label, noninferiority, randomized, controlled trial. Am J Kidney Dis74: 601–609, 2019PubMed
KitrungphaiboonT, PuapatanakulP, ChuengsamanP, TiskajornsiriK, HalueG, SiribamrungwongM, et al: Intraperitoneal cefepime monotherapy versus combination therapy of cefazolin plus ceftazidime for empirical treatment of CAPD-associated peritonitis: A multicenter, open-label, noninferiority, randomized, controlled trial. Am J Kidney Dis 74: 601–609, 2019PubMed)| false
van der HulstRJ, BoeschotenEW, NielsenFW, StruijkDG, DreschlerWD, TangeRA: Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol Relat Spec53: 19–22, 1991PubMed
van der HulstRJ, BoeschotenEW, NielsenFW, StruijkDG, DreschlerWD, TangeRA: Ototoxicity monitoring with ultra-high frequency audiometry in peritoneal dialysis patients treated with vancomycin or gentamicin. ORL J Otorhinolaryngol Relat Spec 53: 19–22, 1991PubMed)| false
KranzerK, ElaminWF, CoxH, SeddonJA, FordN, DrobniewskiF: A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: Implications for the treatment of multidrug-resistant TB. Thorax70: 1070–1077, 2015PubMed
KranzerK, ElaminWF, CoxH, SeddonJA, FordN, DrobniewskiF: A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: Implications for the treatment of multidrug-resistant TB. Thorax 70: 1070–1077, 2015PubMed)| false
Falbo Dos ReisP, BarrettiP, MarinhoL, BalbiAL, AwdishuL, PonceD: Pharmacokinetics of intraperitoneal vancomycin and amikacin in automated peritoneal dialysis patients with peritonitis. Front Pharmacol12: 658014, 2021PubMed
Falbo Dos ReisP, BarrettiP, MarinhoL, BalbiAL, AwdishuL, PonceD: Pharmacokinetics of intraperitoneal vancomycin and amikacin in automated peritoneal dialysis patients with peritonitis. Front Pharmacol 12: 658014, 2021PubMed)| false
TriyawatanyuP, ChariyavilaskulP, PhaisalW, PeerapornratanaS, KanjanabuchT, PraditpornsilpaK, et al: Intraperitoneal cefazolin and ceftazidime during short-dwell exchange in peritoneal dialysis patients with peritonitis. Perit Dial Int 40: 179–184, 2020PubMed)| false
FungWW, ChowKM, LiPK, SzetoCC: Clinical course of peritoneal dialysis-related peritonitis due to non-tuberculosis mycobacterium: A single centre experience spanning 20 years. Perit Dial Int42: 204–211, 2022PubMed
FungWW, ChowKM, LiPK, SzetoCC: Clinical course of peritoneal dialysis-related peritonitis due to non-tuberculosis mycobacterium: A single centre experience spanning 20 years. Perit Dial Int 42: 204–211, 2022PubMed)| false
XuR, ChenY, LuoS, XuY, ZhengB, ZhengY, et al: Clinical characteristics and outcomes of peritoneal dialysis-related peritonitis with different trends of change in effluent white cell count: A longitudinal study. Perit Dial Int33: 436–444, 2013PubMed
XuR, ChenY, LuoS, XuY, ZhengB, ZhengY, et al: Clinical characteristics and outcomes of peritoneal dialysis-related peritonitis with different trends of change in effluent white cell count: A longitudinal study. Perit Dial Int 33: 436–444, 2013PubMed)| false
TantiyavarongP, TraitanonO, ChuengsamanP, PatumanondJ, TasanarongA: Dialysate white blood cell change after initial antibiotic treatment represented the patterns of response in peritoneal dialysis-related peritonitis. Int J Nephrol2016: 6217135, 2016PubMed
TantiyavarongP, TraitanonO, ChuengsamanP, PatumanondJ, TasanarongA: Dialysate white blood cell change after initial antibiotic treatment represented the patterns of response in peritoneal dialysis-related peritonitis. Int J Nephrol 2016: 6217135, 2016PubMed)| false
SzetoCC, NgJK, Wing-Shing FungW, ChanGC, ChengPM, LaiKB, et al: Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: A randomized controlled trial. Clin Kidney J14: 991–997, 2021PubMed
SzetoCC, NgJK, Wing-Shing FungW, ChanGC, ChengPM, LaiKB, et al: Extended antibiotic therapy for the prevention of relapsing and recurrent peritonitis in peritoneal dialysis patients: A randomized controlled trial. Clin Kidney J 14: 991–997, 2021PubMed)| false
PravoverovLV, ZhengS, ParikhR, TanTC, BhallaN, ReddyC, et al: Trends associated with large-scale expansion of peritoneal dialysis within an integrated care delivery model. JAMA Intern Med179: 1537–1542, 2019PubMed
PravoverovLV, ZhengS, ParikhR, TanTC, BhallaN, ReddyC, et al: Trends associated with large-scale expansion of peritoneal dialysis within an integrated care delivery model. JAMA Intern Med 179: 1537–1542, 2019PubMed)| false
CouchoudC, BolignanoD, NistorI, JagerKJ, HeafJ, HeimburgerO, et al; European Renal Best Practice (ERBP) Diabetes Guideline Development Group: Dialysis modality choice in diabetic patients with end-stage kidney disease: A systematic review of the available evidence. Nephrol Dial Transplant30: 310–320, 2015PubMed
CouchoudC, BolignanoD, NistorI, JagerKJ, HeafJ, HeimburgerO, et al; European Renal Best Practice (ERBP) Diabetes Guideline Development Group: Dialysis modality choice in diabetic patients with end-stage kidney disease: A systematic review of the available evidence. Nephrol Dial Transplant 30: 310–320, 2015PubMed)| false
SukulN, MukhopadhyayP, SchaubelDE, PearsonJ, TurenneM, SaranR, et al: Peritoneal dialysis and mortality, kidney transplant, and transition to hemodialysis: Trends from 1996-2015 in the United States. Kidney Med2: 610–619.e1, 2020PubMed
SukulN, MukhopadhyayP, SchaubelDE, PearsonJ, TurenneM, SaranR, et al: Peritoneal dialysis and mortality, kidney transplant, and transition to hemodialysis: Trends from 1996-2015 in the United States. Kidney Med 2: 610–619.e1, 2020PubMed)| false
BayaniDBS, AlmirolBJQ, UyGDC, TaneoMJS, DanguilanRS, ArakamaMI, et al: Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines. Nephrology (Carlton)26: 170–177, 2021PubMed
BayaniDBS, AlmirolBJQ, UyGDC, TaneoMJS, DanguilanRS, ArakamaMI, et al: Filtering for the best policy: An economic evaluation of policy options for kidney replacement coverage in the Philippines. Nephrology (Carlton) 26: 170–177, 2021PubMed)| false
ShukriA, MettangT, ScheckelB, SchellartzI, SimicD, ScholtenN, et al: Hemodialysis and peritoneal dialysis in germany from a health economic view: A propensity score matched analysis. Int J Environ Res Public Health19: 14007, 2022PubMed
ShukriA, MettangT, ScheckelB, SchellartzI, SimicD, ScholtenN, et al: Hemodialysis and peritoneal dialysis in germany from a health economic view: A propensity score matched analysis. Int J Environ Res Public Health 19: 14007, 2022PubMed)| false
BrownEA, PerlJ: Increasing peritoneal dialysis use in response to the COVID-19 pandemic: Will it go viral?J Am Soc Nephrol 31: 1928–1930, 2020PubMed)| false
OkpechiIG, JhaV, ChoY, YeF, IjezieCI, JindalK, et al: The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology (Carlton)27: 391–403, 2022PubMed
OkpechiIG, JhaV, ChoY, YeF, IjezieCI, JindalK, et al: The case for increased peritoneal dialysis utilization in low- and lower-middle-income countries. Nephrology (Carlton) 27: 391–403, 2022PubMed)| false
JohansenKL, ChertowGM, GilbertsonDT, IshaniA, IshraniA, KuE, et al.: US Renal Data System 2022 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis2023;81:Sviii-Sxi;S1-S674.
JohansenKL, ChertowGM, GilbertsonDT, IshaniA, IshraniA, KuE, et al.: US Renal Data System 2022 Annual Data Report: Epidemiology of kidney disease in the United States. Am J Kidney Dis2023;81:Sviii-Sxi;S1-S674.)| false